1. The extent of biliary excretion in the rat of 15 sulphonamide compounds was studied. 2. Most of the sulphonamides studied, with molecular weights from 172 (sulphanilamide) to 352 (N4-acetylsulphadimethoxine) are poorly excreted in the bile (0-4% of the dose), except sulphapyridine, sulphamethoxypyridazine and sulphadimethoxine. The last three are partly metabolized to glucuronides, whose molecular weights and polarities are such as to allow them to be excreted in the bile in appreciable amounts. 3. Succinylsulphathiazole and phthalylsulphathiazole are polar and have molecular weights (355 and 403) of an appropriate order, and are excreted unchanged in the bile in appreciable amounts. 4. Sulphadimethoxine Nl-glucuronide (mol.wt. 487) is extensively excreted in the bile unchanged. 5. The results are examined in the light of the hypotheses put forward in the preceding paper .
Sulphonamide drugs have been extensively studied from the point of view of their metabolic transformations, but relatively little is known about their biliary excretion (see Smith, 1966) . Sulphanilamide is known to be excreted in small amounts in the bile in man (Bettman & Spier, 1939) , dogs (Carryer & Ivy, 1939) and rabbits (Barber, Dible & Haslewood, 1943) . Sulphapyridine is also excreted in the bile in man (Hubbard & Butsch, 1941) and rabbits (Barber et al. 1943 ). On intravenous injection, sulphaphenazole, sulphamethoxypyridazine, sulphasomidine and sulphochloropyridazine appear in the bile of rabbits (Neipp, Sackmaun & Tripod, 1961) . In the present work the biliary excretion of 15 sulphonamides in the rat was examined and the metabolites in the bile were identified in most cases. The results obtained are considered in the light of the suggestions made in the preceding paper on the factors involved in biliary excretion. It is shown that most of the sulphonamides examined are poorly excreted in the bile and that this finding is in accord with the hypotheses elaborated by Millburn et al. (1967) .
MATERIALS AND METHODS
Chemicals. Most of the sulphonamides used were purchased (May and Baker Ltd., Dagenham, Essex) and purified by recrystallization from aqueous ethanol. The N4-acetyl derivatives were prepared by the acetylation of the parent compound with acetic anhydride in saturated Na2CO solution and were recrystallized from aqueous or absolute ethanol. Melting points agreed with those given in the literature. Ammonium 1-deoxy-I-[N1.(2,4-dimethoxypyrimidin-6-yl)sulphanilamido]glucuronate (sulphadimethoxine Nl-glucuronide, ammonium salt), m.p. 150-1600 (decomp.), was prepared by the method of Bridges, Kibby & Williams (1965) .
Determination of &ulphonamidem in bile. Sulphonamides containing a free aromatic primary amino group were estimated colorimetrically (at 540mu) by diazotization and coupling with N-(l-naphthyl)ethylenediamine as described by Abou-El-Makarem, . Total sulphonamides (i.e. free plus acetylated) were estimated similarly after a short acid hydrolysis. The recoveries of the sulphonamides and their N4-acetyl derivatives added to bile (0.1-045mg./ml.) were satisfactory (range 90-100%). Succinyl-and phthalylsulphathiazole were determined as sulphathiazole after acid hydrolysis. Bile samples (3ml.) obtained from rats treated with either of these compounds were heated in stoppered glass tubes for 1 hr. in a boiling-water bath with an equal volume of 2N-HCI. The solution was filtered to remove precipitated bile pigments and a portion of the filtrate (2ml.) was diluted to lOml. Samples (lml.) of the latter were diazotized and coupled as described above.
The recoveries of succinyl-and phthalyl-sulphathiazole added to bile samples (0-2 mg./ml.) and assayed as described above were 89% and 91% respectively. Sulphadimethoxine is excreted in the bile mainly as metabolites and these were estimated individually after separation by paper chromatography. Bile samples (1 ml.), collected from rats injected intraperitoneally with sulphadimethoxine, were chromatographed on Whatman no. 1 paper with solvent (see Table 1 ). After development and drying of the chromatogram, sulphadimethoxine and its metabolites were located on the paper by viewing under u.v. light. Areas of the chromatogram containing the drug Table 1 . Rp values and colour reactionm of suIphonamide drugs Descending chromatography on Whatman no. 1 paper was used. The solvent systems employed were: A, butan-l-ol-acetic acid-water (4:1:2, by vol.); B, butan-l-ol-aq. NH3 (sp.gr. 0-88)-water (10:1:1, by vol.); C, propan-l-ol-aq. NH3 (sp.gr. 0.88) (7:3, v/v). All the compounds gave a red colour immediately on spraying withp-dimethylaminocinnamaldehyde (0.25% in equal volumes of2 N-HCI and ethanol) except the N4-substituted derivatives, which give a red colour in 6-24hr.; phthalylsulphathiazole and sulphadimethoxine N4-glucuronide give the red colour after 3-4min. In u.v. light all the compounds appear on paper as dark spots, except sulphanilamide (purple fluorescence), sulphaguanidine and N4-acetylsulphapyridine (blue fluorescence), and sulphapyridine (blue fluorescence in HCI fumes). The metabolites found in the bile were identified by Rp values and colour reactions (see Table 1 ). The approximate amounts of each metabolite found are given in column 3 (see also 6-3 310 9 (6-11) 1-8 (0-4-3-1) 11 (7-14) 19 (17- and its metabolites were cut out, and the material was eluted with 3% (w/v) NaOH (5-lOml.). The eluates were acidified with 2N-HCI, diluted and assayed as described above. Cannukdion of rat8. Female Wistar albino rats (weighing 200+10g.) were used and cannulated as described in a preceding paper (Abou-El-Makarem et al. 1967 ).
Rp values in solvents Compound
Chromatography. Bile samples (0-05-02ml.) were chromatographed on Whatman no. 1 paper in three solvent systems and the compounds in bile were identified by comparison of their RF values and colour reactions with those given by authentic reference compounds (see Table  1 ). The sulphonamides and their metabolites were detected by viewing the paper with u.v. light and by their colour reactions with p-dimethylaminocinnamaldehyde and naphtharesorcinol reagents (Table 1) .
RESULTS AND DISCUSSION
The nature and the extent of excretion of the metabolites of 15 sulphonamide compounds in the bile in rats are given in Tables 2 and 3 . If one considers the first 12 compounds in Table 3 , i.e. from sulphanilamide up to and including N4-acetylsulphadimethoxine, it is seen that the extent of biliary excretion is low and less than 5% of the dose in all cases except sulphapyridine (11%), sulphamethoxypyridazine (8%) and sulphadimethoxine (11%). It was postulated in the preceding paper ) that for appreciable biliary excretion (i.e. 5-10% or more of the dose) the compound should be highly polar and of molecular weight not less than 325 + 50 or could be converted into such a compound by metabolism. Sulphanilamide, sulphacetamide, sulphaguanidine, sulphadiazine, sulphathiazole, sulphisoxazole, sulphasomizole, N4-acetylsulphathiazole and N4-acetylsulphadimethoxine do not fit these criteria and are poorly excreted in the bile. For N4-acetylsulphadimethoxine the molecular weight, 352, is of the right order, but it is not sufficiently polar and it is not metabolized to a highly polar conjugate.
Sulphapyridine, sulphamethoxypyridazine and sulphadimethoxine, however, are partly metabolized to glucuronides (see Table 2 ). Such glucuronides would be highly polar and would have molecular weights of 441, 472 and 487 respectively, if they were monoglucuronides. The glucuronides of sulphapyridine (2-sulphanilamidopyrid-5-yl glucuronide; Scudi & Childress, 1956 ) and of sulphadimethoxine (sulphadimethoxine Nl-glucuronide; Bridges et al. 1965 ) are known. The formation of these glucuronides probably accounts for the higher biliary excretion of these three drugs compared with the other nine compounds referred to in the preceding paragraph.
The next two compounds in Table 3 the second has an appreciable excretion (11 %). As shown in Table 2 , neither of these compounds is metabolized and both are excreted unchanged in the bile. Their appreciable excretion in the bile in the unchanged state can be explained on the grounds that they meet the criteria for such a biliary excretion . Their molecular weights (355 and 403) are of the right order and both are polar and contain a free carboxyl group. The lower biliary excretion of phthalylsulphathiazole compared with the succinyl derivative may be due to the very low solubility of the former, which may not be readily absorbed from the peritoneal cavity after injection. The last compound in Table 3 is sulphadimethoxine Nl-glucuronide (II), a compound whose properties fit the criteria of molecular weight (487) and polarity (pKa about 3*6) for high biliary excretion in the rat and whose biliary excretion was found to be 78% of the dose. This value should be compared with that of sulphadimethoxine, which is 10-20% of the dose (Tablt 3), but whose major metabolite in the bile is the Nl-glucuronide ( Table  2 ). The extent of biliary excretion of sulphadimethoxine probably depends on the extent to which it is metabolized to the Nl-glucuronide.
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